Target intelligence / Profile preview

Carbohydrate-binding module 17 (CBM17)

Target
CBM17
Molecular classification
Carbohydrate-binding module, Protein domain, Non-catalytic module, Other
01

Overview

Carbohydrate-binding module 17 (CBM17) is a non-catalytic protein domain found in various bacterial carbohydrate-active enzymes, particularly family 5 glycoside hydrolases such as endoglucanases [1, 2]. It belongs to the type-B CBM category, which is characterized by a shallow binding cleft that specifically recognizes and binds to the beta-1,4-glucan chains of non-crystalline (amorphous) cellulose and soluble cellooligosaccharides [3, 14]. Structurally, CBM17 adopts a beta-sandwich fold, often stabilized by calcium ions, and utilizes aromatic and polar amino acid residues to facilitate substrate interaction through CH-pi stacking and hydrogen bonding [14, 30]. Its primary biological function is to anchor the associated catalytic enzyme to the carbohydrate substrate, thereby increasing the local concentration of the enzyme and enhancing the efficiency of polysaccharide degradation [1, 35]. While CBM17 is not a direct therapeutic target for human diseases, it is extensively utilized in biotechnology as a molecular probe for visualizing cellulose accessibility in plant cell walls [18, 31]. Furthermore, it is a key component in the development of "designer" enzymes and multi-enzyme complexes for biomass conversion and biofuel production [20, 34]. Recent research has also explored its use as a targeting moiety in drug delivery systems for treating bacterial biofilms, although it does not currently interact with any approved pharmaceutical drugs [21]. It is primarily found in cellulolytic bacteria such as Clostridium cellulovorans and Bacillus species [6, 7].

Other names
Family 17 carbohydrate-binding moduleCBM family 17Cellulose-binding domain family XVIICBM17
02

Mechanism of action

Not applicable

03

Biological functions

Carbohydrate bindingSubstrate targetingCellulose degradation facilitationOther
04

Disease associations

Other

Beyond the preview

Go deeper on Carbohydrate-binding module 17 (CBM17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbohydrate-binding module 17 (CBM17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call